Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ziprasidone hydrochloride

Known as: 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-Indol-2-one Monohydrochloride, ziprasidone hcl 
The hydrochloride salt form of ziprasidone, a benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic… Expand
National Institutes of Health

Related topics

Related topics

14 relations
Adrenergic alpha-Antagonists [MoA]Antipsychotic AgentsCongestive heart failureDrug Allergy
Expand

Narrower (2)

Geodonziprasidone hydrochloride, monohydrate

Broader (1)

ziprasidone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Mucoadhesive-floating zinc-pectinate-sterculia gum interpenetrating polymer network beads encapsulating ziprasidone HCl.
A novel dual crosslinked low-methoxyl (LM) pectinate-sterculia gum (SG) interpenetrating polymer network (IPN) beads was… Expand
  • table 1180
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2012
2012
In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.
Ziprasidone, commercially available as Geodon capsules, is an atypical antipsychotic used in the treatment of schizophrenia and… Expand
2012
2012
Natural gums as sustained release carriers: development of gastroretentive drug delivery system of ziprasidone HCl
BackgroundObjective of this study is to show the potential use of natural gums in the development of drug delivery systems… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2012
2012
Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state.
Reducing the absorption difference between fed and fasted states is an important goal in the development of pharmaceutical dosage… Expand
2011
2011
Improved Ziprasidone Formulations with Enhanced Bioavailability in the Fasted State and a Reduced Food Effect
ABSTRACTPurposeTo develop and characterize new formulations of ziprasidone with a reduced food effect achieved by increasing… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2011
2011
Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy.
Cryomilling was applied to obtain amorphous forms of the base ziprasidone and its hydrochloride salt. Complete amorphization of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2009
Review
2009
Using oral ziprasidone effectively: the food effect and dose-response
  • L. Citrome
  • Advances in therapy
  • 2009
    • Corpus ID: 207417017
Ziprasidone is a newer “atypical” or “secondgeneration” antipsychotic. Oral ziprasidone (zipras idone hydrochlor ide) has been… Expand
  • figure 1
  • table 1
  • figure 2
Highly Cited
2007
Highly Cited
2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
CONTEXT Neurocognitive impairment in schizophrenia is severe and is an important predictor of functional outcome. The relative… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2004
2004
Neuroleptic malignant syndrome associated with ziprasidone in an adolescent.
BACKGROUND Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal disorder characterized by fever, muscular… Expand
Highly Cited
2000
Highly Cited
2000
The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.
AIMS To assess the effects of multiple oral doses of ketoconazole on the single-dose pharmacokinetics of oral ziprasidone HCl… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE